Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 14888 clinical trials
Hyperimmune Plasma in Patients With COVID-19 Severe Infection

The objective of this study will be to evaluate the efficacy and safety of the hyperimmune plasma administered add-on to the anti-Covid-19 treatment (standard therapy) according to clinical practice in patients with severe Covid-19 infection, compared to patients with severe Covid-19 infection treated only with standard therapy.

blood transfusion
plasma transfusion
acute respiratory syndrome (sars)
covid-19
ebola virus disease
  • 0 views
  • 16 Feb, 2024
  • 6 locations
Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection

The overall objective of the study is to evaluate the safety and efficacy of MSC therapy combined with best supportive care in hospitalized patients with COVID-19.

mental illness
alcoholism
pneumonia
lidocaine
ct scan
  • 0 views
  • 05 Aug, 2020
Treatment of BK Virus Infection With CTL Cells in Immunocompromised Transplant Patients

This is a pilot study using cytotoxic T lymphocytes (CTLs) manufactured with the Miltenyi CliniMACS Prodigy Gamma-capture system will be effective in decreasing specific viral load in patients with BK virus viremia and BK virus-associated symptoms post-allogeneic hematopoietic stem cell transplantation (HSCT), renal transplantation, and chemotherapy.

  • 0 views
  • 16 Feb, 2024
  • 1 location
Convalescent Plasma for the Treatment of Patients With Severe COVID-19 Infection

This is a multicenter, Phase 2 study, to assess the efficacy of the treatment with convalescent plasma in patients with severe COVID-19 infection.

shock
ct scan
covid-19
FIO2
SARS
  • 0 views
  • 05 Aug, 2020
Trial of Inhaled Anti-viral (SNG001) for SARS-CoV-2 (COVID-19) Infection

Addition of IFN- in vitro protects lung cells from viral infection. IFN- protects cells against the MERS and SARS coronaviruses (close relatives of SARS-CoV-2, the virus that causes COVID-19).

COPD
cough
interferon
cardiovascular disease
immunodeficiency
  • 0 views
  • 01 Feb, 2023
  • 9 locations
Prevention of Infection and Incidence of COVID-19 in Medical Personnel Assisting Patients With New Coronavirus Disease

This is a randomized controlled trial of the efficacy and safety evaluation of oral administration of Bromhexine hydrochloride for the prevention of SARS-CoV-2 infection and COVID-19 disease in medical personnel assisting patients with a new coronavirus disease

  • 0 views
  • 16 Feb, 2024
  • 1 location
Clinical Trial to Evaluate the Efficacy of Food Supplement Manremyc Against SARS- COV-2 Infection (COVID-19) in Healthcare Workers

The purpose of this study is to assess the efficacy of Manremyc food supplement for reduce the incidence of SARS-CoV-2 infection in a high risk population, as healthcare workers.

serologic test
SARS
acute respiratory syndrome (sars)
  • 0 views
  • 16 Feb, 2024
  • 5 locations
Analysis of Volatile Organic Compounds by Electronic Noses in Hospitalised Patients for an Infection by SARS-COV-2 (COVID-19)

The VOCs in exhaled air in patients hospitalized for COVID-19 infection are analysed in this study, using electronic noses.

acute respiratory syndrome (sars)
covid-19
respiratory disorder
SARS
volatile organic compounds
  • 0 views
  • 16 Feb, 2024
  • 1 location
Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoV-2 Virus Infection (COVID-19)

Evaluation of the efficacy and safety of NTX in adult patients (18 years and <60 years), with SARS-CoV-2 infection with mild symptoms of COVID-19, compared to a placebo control arm. 135 patients will be randomized to either Nitazoxanide (n=90) or placebo (n=45) (2:1).

nitazoxanide
SARS
acute respiratory syndrome (sars)
covid-19
  • 0 views
  • 05 Aug, 2020
Immunity and Safety of Covid-19 Synthetic Minigene Vaccine

Based on detailed analysis of the viral genome and search for potential immunogenic targets, a synthetic minigene has been engineered based on conserved domains of the viral structural proteins and a polyprotein protease. The infection of Covid-19 is mediated through binding of the Spike protein to the ACEII receptor, and …

  • 0 views
  • 16 Feb, 2024
  • 3 locations